US Broker Ratings

Elanco Animal Health (ELAN) Stock Analysis: Unveiling 39% Upside Potential in the Thriving Animal Health Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands out in the bustling healthcare sector as a key player in the animal health industry, offering innovative solutions for both pets and farm..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 50% Upside Potential Amid Steady Revenue Growth

For investors seeking resilient opportunities in the healthcare sector, Prestige Consumer Healthcare Inc. (PBH) presents a compelling case. This Tarrytown, New York-based company, with a market capitalization of $2.13 billion,..

BrightSpring Health Services, I (BTSG) Stock Analysis: Strong Buy Ratings Signal a 39% Upside Potential

BrightSpring Health Services, I (BTSG), a prominent player in the Health Information Services industry, is capturing investor attention with its significant growth potential. Headquartered in Louisville, Kentucky, this healthcare heavyweight..

HCA Healthcare, Inc. (HCA) Stock Analysis: Potential Upside and Strategic Insights for Investors

HCA Healthcare, Inc. (NYSE: HCA), a titan in the U.S. healthcare sector, commands a significant presence in the medical care facilities industry. With a market capitalization of $94.88 billion, HCA’s..

Guardant Health, Inc. (GH) Stock Analysis: A Strong Buy with 9% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a key player in the diagnostics and research industry within the healthcare sector, is making waves with its innovative approach to cancer diagnostics. Based in..

Waystar Holding Corp. (WAY): Investor Outlook on a Healthcare Tech Leader with 30% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare technology space, is capturing the attention of investors with its innovative solutions and promising financial outlook. The company, headquartered..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook on a Biotech Powerhouse with 27.57% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotechnology sector, with its focus on developing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The company’s flagship product, Rezdiffra, is pioneering..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Promising 37% Upside Potential Amidst Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a leading player in the biotechnology sector focusing on central nervous system (CNS) disorders, is capturing significant attention from investors. With a market capitalization of..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking the 173.67% Return on Equity and Revenue Surge

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has captured investor attention with its impressive financial metrics and strategic partnerships. Headquartered in San Diego, California, Halozyme..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Analyst Ratings and 9% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the United States’ healthcare sector, continues to capture investor attention with a robust market capitalization of $21.1 billion. As a leading..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 7.75% Upside Potential Amidst Strategic Collaborations

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading global player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, presents a compelling case for investors with..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Promising 58% Upside Potential in the Biotech Arena

Telix Pharmaceuticals Limited (ASX: TLX), an Australian biopharmaceutical company specializing in radiopharmaceuticals, is capturing investor attention with its impressive potential upside of 58.27% as indicated by its average target price...

ADMA Biologics Inc (ADMA) Stock Analysis: Potential Upside of 86.61% Sparks Investor Interest

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of $2.04..

Teleflex Incorporated (TFX) Stock Analysis: Potential 23% Upside Amid Strong Revenue Growth

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing investor attention with a notable potential upside of 23.31%...

Vaxcyte, Inc. (PCVX) Stock Analysis: An Insight into Its 87.51% Potential Upside

In the dynamic field of biotechnology, Vaxcyte, Inc. (NASDAQ: PCVX) is making significant strides with its innovative approach to vaccine development. As a clinical-stage company, Vaxcyte is at the forefront..

Alkermes plc (ALKS) Stock Analysis: A Look at its 29.88% Potential Upside

Alkermes plc (NASDAQ: ALKS), based in Dublin, Ireland, is a leading player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry. With a market capitalization..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 41% Potential Upside

For investors eyeing opportunities in the healthcare sector, Align Technology, Inc. (NASDAQ: ALGN) offers an intriguing prospect. Known for its innovative Invisalign clear aligners and iTero intraoral scanners, the company..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A 9.6% Potential Upside in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a global pharmaceutical giant headquartered in Hyderabad, India, continues to stand out in the healthcare sector, specifically within the specialty and generic drug manufacturing..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Titan with a 10% Potential Upside

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, has carved a niche for itself in the realm of digital health and cloud-connected medical devices. With a market..

Insulet Corporation (PODD) Stock Analysis: Exploring a 22% Potential Upside in the Medical Device Sector

Insulet Corporation (NASDAQ: PODD), a leader in the healthcare sector specializing in medical devices, particularly insulin delivery systems, offers intriguing prospects for investors. With a market capitalization of $9.75 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds